AAPS Open (Record no. 189702)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01783nas a22002895i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 2364-9534 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20180511105621.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 150723s||||||||gw uu poo|||||| b|EN |d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2364-9534 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 41120 |
| Source of number or code | local |
| 210 10 - ABBREVIATED TITLE | |
| Abbreviated title | AAPS Open |
| 245 10 - TITLE STATEMENT | |
| Title | AAPS Open |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Christopher M. Riley. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing : |
| -- | Imprint: Springer. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Other physical details | online resource. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | AAPS Open provides a global forum for the rapid and barrier-free publication of reports of original research that demonstrates applications of scientific concepts and techniques across the breadth of the pharmaceutical sciences. Fully peer-reviewed, AAPS Open supports the international community of experts in pharmaceutical sciences by providing a venue for articles that further the understanding of all aspects of the field. A high degree of innovation is not a required element for publication; the journal seeks to publish papers that are technically sound. AAPS Open welcomes reports from experimental or theoretical studies during the normal course of development of a drug candidate, e.g., assay development and validation, formulation, stability, metabolism screening, bioavailability assessment and comparison, food effects studies, manufacturing approaches, and so forth. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmaceutical technology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmaceutical Sciences/Technology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacology/Toxicology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Riley, Christopher M. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://link.springer.com/journal/41120">http://link.springer.com/journal/41120</a> |
| Public note | Open Access |
No items available.